Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG, TBCRC and NABCG intergroup study.
Type of Study: Epidemiological
Sponsor / Support: EORTC
Primary Objectives: To perform a prospective registry of all male breast cancer patients irrespective of the stage and treatment.
Design: A retrospective, prospective, analytical and observational study.
Sample Size: 533 patients
Principal Investigator: Gustavo Werutsky (Steering Committee – LACOG)
Countries LATAM: Brazil, Mexico and Peru
Ongoing studies
Breast
GBECAM 0115 – AMAZONA III
LACOG 0221 – BRAVE
LACOG 0413 – Male Breast Cancer
LACOG 0419 – NEOSAMBA
LACOG 0615 – LATINABreast
LACOG 0715 – PALLAS
LACOG 2118 – ALEXANDRA/IMpassion 030
Gastrointestinal
LACOG/GTG 1318 – CCA
LACOG 0119
Gynecological
LACOG 0215 – EVITA
LACOG 0820 – EVITA LATAM
LACOG 0920 – Senticol III
LACOG 1018 – PALBO in Ovarian Cancer
Genitourinary
LACOG 0217 – IRONMAN
LACOG 0218 – Hercules
LACOG 0415 – APA in Prostate Cancer
LACOG 0515 – Testicular Registry
LACOG 0519 – PEACE III
LACOG 0620 – ExBAT
LACOG 1120 – RENAL REGISTRY
LACOG 1518 – Bladder Cancer Registry
LACOG 1818 – Prostate Cancer Registry
Head and Neck
LACOG 0318 – Induction
LACOG 0319
LACOG 0720 – SMART-KEY
Lung
LACOG 0116 – LATINO LUNG
LACOG 0118 – RELANCE
LACOG 0417 – CNS MTX
LACOG 0618
LACOG 0718 – PCI Project
LACOG 1918
LACOG 2218 – PACIFIC BRAZIL
Neuro
LACOG 0619